{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T16:06:41Z","timestamp":1775059601105,"version":"3.50.1"},"reference-count":179,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.intimp.2022.108938","type":"journal-article","created":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T11:27:49Z","timestamp":1656070069000},"page":"108938","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Interleukin-35 ameliorates cardiovascular disease by suppressing inflammatory responses and regulating immune homeostasis"],"prefix":"10.1016","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8729-650X","authenticated-orcid":false,"given":"Jie","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanqing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.intimp.2022.108938_b0005","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the american college of cardiology\/american heart association task force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation."},{"issue":"34","key":"10.1016\/j.intimp.2022.108938_b0010","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.intimp.2022.108938_b0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng.2480","article-title":"Large-scale association analysis identifies new risk loci for coronary artery disease","volume":"45","author":"Deloukas","year":"2013","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.intimp.2022.108938_b0020","article-title":"Heart disease and stroke statistics\u20142016 update: a report from the american heart association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.intimp.2022.108938_b0025","first-page":"1743","article-title":"Global health and cardiovascular disease","volume":"100","author":"Nascimento","year":"2014","journal-title":"Global health and cardiovascular dis. HEART."},{"issue":"4","key":"10.1016\/j.intimp.2022.108938_b0030","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41569-018-0119-4","article-title":"Epidemiology of cardiovascular disease in China: current features and implications","volume":"16","author":"Zhao","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"issue":"5","key":"10.1016\/j.intimp.2022.108938_b0035","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1161\/HYPERTENSIONAHA.121.18075","article-title":"Arteriosclerosis, atherosclerosis, and cardiovascular health: joint relations to the incidence of cardiovascular disease","volume":"78","author":"Vasan","year":"2021","journal-title":"Hypertension."},{"issue":"25","key":"10.1016\/j.intimp.2022.108938_b0040","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1016\/j.jacc.2020.11.021","article-title":"The Global burden of cardiovascular diseases and risks","volume":"76","author":"Roth","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.intimp.2022.108938_b0045","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/ageing\/afab083","article-title":"Burden of cardiovascular diseases in older adults using aged care services","volume":"50","author":"Hsu","year":"2021","journal-title":"Age Ageing."},{"issue":"5","key":"10.1016\/j.intimp.2022.108938_b0050","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.carpath.2015.05.001","article-title":"Consensus statement on surgical pathology of the aorta from the society for cardiovascular pathology and the association for european cardiovascular pathology: I","volume":"24","author":"Stone","year":"2015","journal-title":"Inflammatory dis. Cardiovasc Pathol."},{"key":"10.1016\/j.intimp.2022.108938_b0055","doi-asserted-by":"crossref","first-page":"100822","DOI":"10.1016\/j.mam.2019.09.006","article-title":"Emerging role of mitophagy in cardiovascular physiology and pathology","volume":"71","author":"Morales","year":"2020","journal-title":"Mol. Aspects Med."},{"issue":"7","key":"10.1016\/j.intimp.2022.108938_b0060","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.celrep.2017.10.090","article-title":"Reciprocal Expression of IL-35 and IL-10 Defines Two Distinct Effector Treg Subsets that Are Required for Maintenance of Immune Tolerance","volume":"21","author":"Wei","year":"2017","journal-title":"Cell Rep."},{"issue":"11","key":"10.1016\/j.intimp.2022.108938_b0065","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1089\/jir.2021.0147","article-title":"Interleukin-35: structure, function and its impact on immune-related diseases","volume":"41","author":"Ye","year":"2021","journal-title":"J. Interferon & Cytokine Res."},{"issue":"1","key":"10.1016\/j.intimp.2022.108938_b0070","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-014-0080-6","article-title":"Immunosuppressive\/anti-inflammatory cytokines directly and indirectly inhibit endothelial dysfunction- a novel mechanism for maintaining vascular function","volume":"7","author":"Shao","year":"2014","journal-title":"J. Hematol. Oncol."},{"issue":"7","key":"10.1016\/j.intimp.2022.108938_b0075","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1161\/ATVBAHA.112.249706","article-title":"Interleukin-12p35 deletion promotes CD4 T-Cell\u2013dependent macrophage differentiation and enhances angiotensin II\u2013induced cardiac fibrosis","volume":"32","author":"Li","year":"2012","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biol."},{"issue":"31","key":"10.1016\/j.intimp.2022.108938_b0080","doi-asserted-by":"crossref","first-page":"19307","DOI":"10.1074\/jbc.M115.663286","article-title":"Interleukin-35 inhibits endothelial cell activation by suppressing MAPK-AP-1 pathway","volume":"290","author":"Sha","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.intimp.2022.108938_b0085","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nm.3554","article-title":"Interleukin-35 induces regulatory B cells that suppress autoimmune disease","volume":"20","author":"Wang","year":"2014","journal-title":"Nat. Med."},{"issue":"7492","key":"10.1016\/j.intimp.2022.108938_b0090","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nature12979","article-title":"IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases","volume":"507","author":"Shen","year":"2014","journal-title":"Nature."},{"key":"10.1016\/j.intimp.2022.108938_b0095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.758554","article-title":"Association between interleukin 35 gene single nucleotide polymorphisms and the uveitis immune status in a chinese han population","volume":"12","author":"Feng","year":"2021","journal-title":"Front Immunol."},{"issue":"22","key":"10.1016\/j.intimp.2022.108938_b0100","doi-asserted-by":"crossref","first-page":"12041","DOI":"10.1073\/pnas.94.22.12041","article-title":"Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin","volume":"94","author":"Devergne","year":"1997","journal-title":"Proceedings of the National Academy of Sci."},{"issue":"7169","key":"10.1016\/j.intimp.2022.108938_b0105","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nature06306","article-title":"The inhibitory cytokine IL-35 contributes to regulatory T-cell function","volume":"450","author":"Collison","year":"2007","journal-title":"Nature."},{"key":"10.1016\/j.intimp.2022.108938_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2017.10.010","article-title":"The IL-12 cytokine family in cardiovascular diseases","volume":"122","author":"van der Heijden","year":"2019","journal-title":"Cytokine."},{"issue":"6","key":"10.1016\/j.intimp.2022.108938_b0115","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/eji.201546095","article-title":"A novel IL-23p19\/Ebi3 (IL-39) cytokine mediates inflammation in Lupus-like mice","volume":"46","author":"Wang","year":"2016","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2022.108938_b0120","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/ni.2227","article-title":"The composition and signaling of the IL-35 receptor are unconventional","volume":"13","author":"Collison","year":"2012","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2022.108938_b0125","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s12026-018-8998-3","article-title":"IL-35: a new immunomodulator in autoimmune rheumatic diseases","volume":"66","author":"Sakkas","year":"2018","journal-title":"Immunol. Res."},{"key":"10.1016\/j.intimp.2022.108938_b0130","doi-asserted-by":"crossref","first-page":"154076","DOI":"10.1016\/j.cyto.2017.06.003","article-title":"IL-35, as a newly proposed homeostasis-associated molecular pattern, plays three major functions including anti-inflammatory initiator, effector, and blocker in cardiovascular diseases","volume":"122","author":"Li","year":"2019","journal-title":"Cytokine."},{"issue":"3","key":"10.1016\/j.intimp.2022.108938_b0135","doi-asserted-by":"crossref","first-page":"e33628","DOI":"10.1371\/journal.pone.0033628","article-title":"IL-35 Is a novel responsive anti-inflammatory cytokine \u2014 a new system of categorizing anti-inflammatory cytokines","volume":"7","author":"Li","year":"2012","journal-title":"Plos One."},{"issue":"4","key":"10.1016\/j.intimp.2022.108938_b0140","doi-asserted-by":"crossref","first-page":"e96120","DOI":"10.1371\/journal.pone.0096120","article-title":"Contribution of IL-12\/IL-35 common subunit p35 to maintaining the testicular immune privilege","volume":"9","author":"Terayama","year":"2014","journal-title":"Plos One."},{"issue":"1","key":"10.1016\/j.intimp.2022.108938_b0145","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-06268-0","article-title":"Macrophage-secreted interleukin-35 regulates cancer cell plasticity to facilitate metastatic colonization","volume":"9","author":"Lee","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2022.108938_b0150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.607315","article-title":"IL10- and IL35-Secreting MutuDC lines act in cooperation to inhibit memory T Cell activation through LAG-3 expression","volume":"12","author":"Koga","year":"2021","journal-title":"Front Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2022.108938_b0155","doi-asserted-by":"crossref","DOI":"10.4067\/S0034-98872010000600015","article-title":"Interleukin (IL)-35 is raising our expectations","volume":"138","author":"Ning-wei","year":"2010","journal-title":"Revista m\u00e9dica de Chile."},{"issue":"1","key":"10.1016\/j.intimp.2022.108938_b0160","doi-asserted-by":"crossref","DOI":"10.1186\/s12950-017-0164-5","article-title":"Interleukin-35 on B cell and T cell induction and regulation","volume":"14","author":"Huang","year":"2017","journal-title":"J. Inflammation."},{"key":"10.1016\/j.intimp.2022.108938_b0165","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/978-94-024-0921-5_10","article-title":"The immunobiology of interleukin-35 and Its regulation and gene expression","volume":"941","author":"Song","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2022.108938_b0170","article-title":"Tumour-derived Interleukin 35 promotes pancreatic ductal adenocarcinoma cell extravasation and metastasis by inducing ICAM1 expression","volume":"8","author":"Huang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2022.108938_b0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2013.00315","article-title":"Interleukin 35: A Key Mediator of Suppression and the Propagation of Infectious Tolerance","volume":"4","author":"Olson","year":"2013","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2022.108938_b0180","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3892\/mmr.2017.6605","article-title":"Regulatory B cells in infectious disease","volume":"16","author":"Dai","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2022.108938_b0185","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/imm.13044","article-title":"Interleukin-35 in immune-related diseases: protection or destruction","volume":"157","author":"Zhang","year":"2019","journal-title":"Immunology."},{"issue":"1","key":"10.1016\/j.intimp.2022.108938_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2020.07.019","article-title":"Interleukin 35 Regulatory B Cells","volume":"433","author":"Choi","year":"2021","journal-title":"J. Mol. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2022.108938_b0195","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jdermsci.2018.11.008","article-title":"Regulatory and effector B cells: friends or foes?","volume":"93","author":"Matsushita","year":"2019","journal-title":"J. Dermatol. Sci."},{"issue":"12","key":"10.1016\/j.intimp.2022.108938_b0200","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/ni.1952","article-title":"IL-35-mediated induction of a potent regulatory T cell population","volume":"11","author":"Collison","year":"2010","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2022.108938_b0205","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/imr.12175","article-title":"Lineage stability and phenotypic plasticity of Foxp3+regulatory T cells","volume":"259","author":"Hori","year":"2014","journal-title":"Immunol. Rev."},{"issue":"12","key":"10.1016\/j.intimp.2022.108938_b0210","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/ni.3577","article-title":"Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression","volume":"17","author":"Gerriets","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2022.108938_b0215","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.intimp.2016.03.009","article-title":"CD4 + CD25 + regulatory T cells in tumor immunity","volume":"34","author":"Chen","year":"2016","journal-title":"Int Immunopharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2022.108938_b0220","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cyto.2012.07.007","article-title":"Porcine T-helper and regulatory T cells exhibit versatile mRNA expression capabilities for cytokines and co-stimulatory molecules","volume":"60","author":"K\u00e4ser","year":"2012","journal-title":"Cytokine."},{"issue":"1","key":"10.1016\/j.intimp.2022.108938_b0225","article-title":"Imbalance of Th17\/Tregs in rats with smoke inhalation-induced acute lung injury","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep.-UK"},{"issue":"7","key":"10.1016\/j.intimp.2022.108938_b0230","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.4049\/jimmunol.1100106","article-title":"Increased Th17 and regulatory T Cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis","volume":"188","author":"Liu","year":"2012","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2022.108938_b0235","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1007\/s00018-011-0907-z","article-title":"The battle against immunopathology: infectious tolerance mediated by regulatory T cells","volume":"69","author":"Gravano","year":"2012","journal-title":"CELL MOL. LIFE SCI."},{"issue":"4","key":"10.1016\/j.intimp.2022.108938_b0240","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.celrep.2019.12.081","article-title":"Treg-Cell-Derived IL-35-coated extracellular vesicles promote infectious tolerance","volume":"30","author":"Sullivan","year":"2020","journal-title":"CELL REP."},{"key":"10.1016\/j.intimp.2022.108938_b0245","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.611795","article-title":"Immunosuppressive Mechanisms of Regulatory B Cells","volume":"12","author":"Catal\u00e1n","year":"2021","journal-title":"FRONT IMMUNOL."},{"issue":"6","key":"10.1016\/j.intimp.2022.108938_b0250","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/eji.201445217","article-title":"Human tolerogenic dendritic cells produce IL-35 in the absence of other IL-12 family members","volume":"45","author":"Dixon","year":"2015","journal-title":"EUR. J. IMMUNOL."},{"issue":"3","key":"10.1016\/j.intimp.2022.108938_b0255","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00054725-200108000-00006","article-title":"The Expression of IL-12 p40 and Its homologue, epstein-barr virus-induced gene 3","volume":"7","author":"Omata","year":"2001","journal-title":"Inflammatory Bowel Dis. INFLAMM. BOWEL. DIS."},{"issue":"8","key":"10.1016\/j.intimp.2022.108938_b0260","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/rheumatology\/keu528","article-title":"Immunoregulatory role of IL-35 in T cells of patients with rheumatoid arthritis","volume":"54","author":"Nakano","year":"2015","journal-title":"Rheumatology."},{"issue":"1","key":"10.1016\/j.intimp.2022.108938_b0265","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.imlet.2008.11.001","article-title":"IL4 blockade of inducible regulatory T cell differentiation: The role of Th2 cells, Gata3 and PU.1","volume":"122","author":"Hadjur","year":"2009","journal-title":"Immunol Lett."},{"key":"10.1016\/j.intimp.2022.108938_b0270","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.cyto.2018.05.019","article-title":"Emerging IL-12 family cytokines in the fight against fungal infections","volume":"111","author":"Thompson","year":"2018","journal-title":"Cytokine."},{"issue":"12","key":"10.1016\/j.intimp.2022.108938_b0275","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.4049\/jimmunol.1200936","article-title":"IL-10 Produced by Induced Regulatory T Cells (iTregs) Controls Colitis and Pathogenic Ex-iTregs during Immunotherapy","volume":"189","author":"Schmitt","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2022.108938_b0280","doi-asserted-by":"crossref","first-page":"154817","DOI":"10.1016\/j.cyto.2019.154817","article-title":"Pancreatic cancer-associated inflammation drives dynamic regulation of p35 and Ebi3","volume":"125","author":"Michaud","year":"2020","journal-title":"Cytokine."},{"issue":"5","key":"10.1016\/j.intimp.2022.108938_b0285","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cytogfr.2015.07.013","article-title":"Interleukin 35: Critical regulator of immunity and lymphocyte-mediated diseases","volume":"26","author":"Egwuagu","year":"2015","journal-title":"Cytokine Growth F R."},{"issue":"6","key":"10.1016\/j.intimp.2022.108938_b0290","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1159\/000491615","article-title":"Interleukin-35 Suppresses the Antitumor Activity of T Cells in Patients with Non-Small Cell Lung Cancer","volume":"47","author":"Wang","year":"2018","journal-title":"Cell Physiol Biochem."},{"issue":"2","key":"10.1016\/j.intimp.2022.108938_b0295","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/cei.13535","article-title":"Interleukin-35 has a tumor-promoting role in hepatocellular carcinoma","volume":"203","author":"Liu","year":"2021","journal-title":"CLIN. EXP. IMMUNOL."},{"issue":"4","key":"10.1016\/j.intimp.2022.108938_b0300","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2500\/ajra.2015.29.4188","article-title":"Cytokine Modulation by IL-35 in Mice with Allergic Rhinitis","volume":"29","author":"Yokota","year":"2015","journal-title":"AM. J. RHINOL ALLERGY."},{"key":"10.1016\/j.intimp.2022.108938_b0305","article-title":"Selenium Deficiency Aggravates Heat Stress Pneumonia in Chickens by Disrupting the M1\/M2 Balance","author":"Yin","year":"2021","journal-title":"BIOL. TRACE ELEM. RES."},{"issue":"7","key":"10.1016\/j.intimp.2022.108938_b0310","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1042\/CS20180879","article-title":"Interleukin-35 promotes early endothelialization after stent implantation by regulating macrophage activation","volume":"133","author":"Liu","year":"2019","journal-title":"CLIN. SCI."},{"issue":"6","key":"10.1016\/j.intimp.2022.108938_b0315","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.4049\/jimmunol.1600446","article-title":"IL-35 Decelerates the Inflammatory Process by Regulating Inflammatory Cytokine Secretion and M1\/M2 Macrophage Ratio in Psoriasis","volume":"197","author":"Zhang","year":"2016","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2022.108938_b0320","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1111\/febs.14801","article-title":"IL-35 ameliorates collagen-induced arthritis by promoting TNF\u2013induced apoptosis of synovial fibroblasts and stimulating M2 macrophages polarization","volume":"286","author":"Peng","year":"2019","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.intimp.2022.108938_b0325","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-017-0393-1","article-title":"Lipopolysaccharide pretreatment increases protease-activated receptor-2 expression and monocyte chemoattractant protein-1 secretion in vascular endothelial cells","volume":"24","author":"Chao","year":"2017","journal-title":"J. BIOMED. SCI."},{"issue":"9","key":"10.1016\/j.intimp.2022.108938_b0330","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.cellsig.2009.04.006","article-title":"Differential involvement of PKC-dependent MAPKs activation in lipopolysaccharide-induced AP-1 expression in human tracheal smooth muscle cells","volume":"21","author":"Lin","year":"2009","journal-title":"CELL SIGNAL."},{"issue":"1","key":"10.1016\/j.intimp.2022.108938_b0335","doi-asserted-by":"crossref","DOI":"10.1186\/s12950-019-0217-z","article-title":"IL-35 alleviates inflammation progression in a rat model of diabetic neuropathic pain via inhibition of JNK signaling","volume":"16","author":"Jiang","year":"2019","journal-title":"J. Inflammation."},{"issue":"1","key":"10.1016\/j.intimp.2022.108938_b0340","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1600-065X.2008.00704.x","article-title":"Interleukin-35: odd one out or part of the family?","volume":"226","author":"Collison","year":"2008","journal-title":"IMMUNOL. REV."},{"issue":"1","key":"10.1016\/j.intimp.2022.108938_b0345","article-title":"IL-6\/IL-12 Cytokine Receptor Shuffling of Extra- and Intracellular Domains Reveals Canonical STAT Activation via Synthetic IL-35 and IL-39 Signaling","volume":"7","author":"Floss","year":"2017","journal-title":"SCI. REP. UK"},{"issue":"1","key":"10.1016\/j.intimp.2022.108938_b0350","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-00838-4","article-title":"IL-12p35 induces expansion of IL-10 and IL-35-expressing regulatory B cells and ameliorates autoimmune disease","volume":"8","author":"Dambuza","year":"2017","journal-title":"NAT. COMMUN."},{"issue":"5","key":"10.1016\/j.intimp.2022.108938_b0355","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1159\/000453165","article-title":"IL-35 Inhibits Angiogenesis through VEGF\/Ang2\/Tie2 Pathway in Rheumatoid Arthritis","volume":"40","author":"Jiang","year":"2016","journal-title":"CELL PHYSIOL. BIOCHEM."},{"key":"10.1016\/j.intimp.2022.108938_b0360","doi-asserted-by":"crossref","first-page":"106725","DOI":"10.1016\/j.intimp.2020.106725","article-title":"Interleukin-35 pretreatment attenuates lipopolysaccharide-induced heart injury by inhibition of inflammation, apoptosis and fibrotic reactions","volume":"86","author":"Hu","year":"2020","journal-title":"INT. IMMUNOPHARMACOL."},{"key":"10.1016\/j.intimp.2022.108938_b0365","doi-asserted-by":"crossref","first-page":"155225","DOI":"10.1016\/j.cyto.2020.155225","article-title":"Epstein-Barr virus-induced gene 3 (EBI3) single nucleotide polymorphisms and their association with central obesity and risk factors for cardiovascular disease: the GEA study","volume":"135","author":"Posadas-S\u00e1nchez","year":"2020","journal-title":"CYTOKINE."},{"key":"10.1016\/j.intimp.2022.108938_b0370","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.00129","article-title":"Roles and mechanisms of interleukin-12 family members in cardiovascular diseases: opportunities and challenges","volume":"11","author":"Ye","year":"2020","journal-title":"FRONT PHARMACOL."},{"issue":"5","key":"10.1016\/j.intimp.2022.108938_b0375","first-page":"820","article-title":"IL-35 prevent bone loss through promotion of bone formation and angiogenesis in rheumatoid arthritis","volume":"37","author":"Liu","year":"2019","journal-title":"CLIN EXP RHEUMATOL."},{"issue":"2","key":"10.1016\/j.intimp.2022.108938_b0380","doi-asserted-by":"crossref","first-page":"112784","DOI":"10.1016\/j.yexcr.2021.112784","article-title":"Interleukin-35 inhibits lipopolysaccharide-induced endothelial cell activation by downregulating inflammation and apoptosis","volume":"407","author":"Li","year":"2021","journal-title":"EXP. CELL RES."},{"key":"10.1016\/j.intimp.2022.108938_b0385","doi-asserted-by":"crossref","first-page":"101373","DOI":"10.1016\/j.redox.2019.101373","article-title":"Anti-inflammatory cytokines IL-35 and IL-10 block atherogenic lysophosphatidylcholine-induced, mitochondrial ROS-mediated innate immune activation, but spare innate immune memory signature in endothelial cells","volume":"28","author":"Li","year":"2020","journal-title":"REDOX. BIOL."},{"key":"10.1016\/j.intimp.2022.108938_b0390","article-title":"IL-35 promotes CD4+Foxp3+ Tregs and inhibits atherosclerosis via maintaining CCR5-amplified Treg-suppressive mechanisms","author":"Ying Shao","year":"2021","journal-title":"RES. ARTICLE"},{"key":"10.1016\/j.intimp.2022.108938_b0395","first-page":"1","article-title":"Interleukin-12p35 Deficiency Reverses the Th1\/Th2 Imbalance, Aggravates the Th17\/Treg Imbalance, and Ameliorates Atherosclerosis in ApoE-\/- Mice","volume":"2019","author":"Huang","year":"2019","journal-title":"MEDIAT INFLAMM."},{"issue":"9","key":"10.1016\/j.intimp.2022.108938_b0400","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1161\/CIRCRESAHA.118.314569","article-title":"Interleukin-35 promotes macrophage survival and improves wound healing after myocardial infarction in mice","volume":"124","author":"Jia","year":"2019","journal-title":"CIRC RES."},{"key":"10.1016\/j.intimp.2022.108938_b0405","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.595813","article-title":"Interleukin 35 delays hindlimb ischemia-induced angiogenesis through regulating ROS-extracellular matrix but spares later regenerative angiogenesis","volume":"11","author":"Fu","year":"2020","journal-title":"FRONT IMMUNOL."},{"key":"10.1016\/j.intimp.2022.108938_b0410","article-title":"Interleukin-35 Is involved in angiogenesis\/bone remodeling coupling through T helper 17\/interleukin-17 Axis","volume":"12","author":"Zhang","year":"2021","journal-title":"FRONT ENDOCRINOL."},{"issue":"3","key":"10.1016\/j.intimp.2022.108938_b0415","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1161\/ATVBAHA.117.310626","article-title":"IL-35 (Interleukin-35) Suppresses Endothelial Cell Activation by Inhibiting Mitochondrial Reactive Oxygen Species-Mediated Site-Specific Acetylation of H3K14 (Histone 3 Lysine 14)","volume":"38","author":"Li","year":"2018","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biol."},{"issue":"6","key":"10.1016\/j.intimp.2022.108938_b0420","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.immuni.2013.06.009","article-title":"Immune effector mechanisms implicated in atherosclerosis: from mice to humans","volume":"38","author":"Libby","year":"2013","journal-title":"IMMUNITY."},{"issue":"4","key":"10.1016\/j.intimp.2022.108938_b0425","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nrcardio.2015.5","article-title":"Anti-inflammatory therapies for atherosclerosis","volume":"12","author":"B\u00e4ck","year":"2015","journal-title":"NAT. REV. CARDIOL."},{"issue":"1","key":"10.1016\/j.intimp.2022.108938_b0430","first-page":"5","article-title":"Innate Immunity in Coronary Disease. the role of interleukin-12 cytokine family in Atherosclerosis. Revista de investigacion","volume":"70","author":"Posadas-S\u00e1nchez","year":"2018","journal-title":"Clinica."},{"issue":"3","key":"10.1016\/j.intimp.2022.108938_b0435","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1016\/j.ijcard.2013.03.026","article-title":"Regulatory T cells prevent plaque disruption in apolipoprotein E-knockout mice","volume":"168","author":"Meng","year":"2013","journal-title":"INT. J. CARDIOL."},{"issue":"5","key":"10.1016\/j.intimp.2022.108938_b0440","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/s10875-012-9699-7","article-title":"CD4+LAP+ and CD4+CD25+Foxp3+ regulatory T cells induced by nasal oxidized low-density lipoprotein suppress effector T cells response and attenuate atherosclerosis in ApoE\u2212\/\u2212 Mice","volume":"32","author":"Zhong","year":"2012","journal-title":"J. CLIN. IMMUNOL."},{"issue":"4","key":"10.1016\/j.intimp.2022.108938_b0445","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.3892\/etm.2016.3649","article-title":"IL-35 improves Treg-mediated immune suppression in atherosclerotic mice","volume":"12","author":"Tao","year":"2016","journal-title":"EXP. THER. MED."},{"issue":"1","key":"10.1016\/j.intimp.2022.108938_b0450","doi-asserted-by":"crossref","first-page":"986","DOI":"10.2741\/3657","article-title":"Th 17 cells interplay with Foxp3+ Tregs in regulation of inflammation and autoimmunity","volume":"15","author":"Mai","year":"2010","journal-title":"Frontiers in Bioscience."},{"issue":"7329","key":"10.1016\/j.intimp.2022.108938_b0455","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A role for mitochondria in NLRP3 inflammasome activation","volume":"469","author":"Zhou","year":"2011","journal-title":"NATURE."},{"key":"10.1016\/j.intimp.2022.108938_b0460","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jaut.2012.12.004","article-title":"FOXP3: Genetic and epigenetic implications for autoimmunity","volume":"41","author":"Katoh","year":"2013","journal-title":"J. AUTOIMMUN."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2022.108938_b0465","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.imlet.2013.01.014","article-title":"Regulatory T cells in atherosclerosis and strategies to induce the endogenous atheroprotective immune response","volume":"151","author":"Chistiakov","year":"2013","journal-title":"IMMUNOL LETT."},{"issue":"2","key":"10.1016\/j.intimp.2022.108938_b0470","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nm1343","article-title":"Natural regulatory T cells control the development of atherosclerosis in mice","volume":"12","author":"Ait-Oufella","year":"2006","journal-title":"NAT. MED."},{"issue":"1","key":"10.1016\/j.intimp.2022.108938_b0475","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1385\/CT:6:1:39","article-title":"Nicotine Enhances Human Vascular Endothelial Cell Expression of ICAM-1 and VCAM-1 Via Protein Kinase C, p38 Mitogen-Activated Protein Kinase, NF-\u03baB, and AP-1","volume":"6","author":"Ueno","year":"2006","journal-title":"CARDIOVASC TOXICOL."},{"issue":"1","key":"10.1016\/j.intimp.2022.108938_b0480","doi-asserted-by":"crossref","first-page":"440","DOI":"10.2353\/ajpath.2009.080752","article-title":"Epstein-Barr Virus-Induced Gene-3 Is Expressed in Human Atheroma Plaques","volume":"175","author":"Kempe","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.intimp.2022.108938_b0485","article-title":"Interleukin-35 Mitigates ox-LDL-induced proatherogenic effects via modulating miRNAs associated with coronary artery disease (CAD)","author":"Bhansali","year":"2022","journal-title":"CARDIOVASC DRUG THER."},{"issue":"12","key":"10.1016\/j.intimp.2022.108938_b0490","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.humimm.2018.10.009","article-title":"IL-35 promoted STAT3 phosphorylation and IL-10 production in B cells, but its production was reduced in patients with coronary artery diseases","volume":"79","author":"Zhu","year":"2018","journal-title":"HUM IMMUNOL."},{"issue":"04\/2018","key":"10.1016\/j.intimp.2022.108938_b0495","doi-asserted-by":"crossref","DOI":"10.7754\/Clin.Lab.2017.170930","article-title":"Circulating Levels of IL-35 and gene expression of foxp3 in coronary artery disease: is there any interplay between them and 25-Hydroxyvitamin D3?","volume":"64","author":"Shateri","year":"2018","journal-title":"CLIN. LAB."},{"issue":"9","key":"10.1016\/j.intimp.2022.108938_b0500","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2174\/1381612820666141014123810","article-title":"Novel Anti-inflammatory interleukin-35 as an emerging target for Anti-atherosclerotic therapy","volume":"21","author":"Bobryshev","year":"2015","journal-title":"CURR. PHARM. DESIGN."},{"issue":"21","key":"10.1016\/j.intimp.2022.108938_b0505","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1056\/NEJMra1216063","article-title":"Mechanisms of acute coronary syndromes and their implications for therapy","volume":"368","author":"Libby","year":"2013","journal-title":"NEW ENGL. J. MED."},{"issue":"4","key":"10.1016\/j.intimp.2022.108938_b0510","doi-asserted-by":"crossref","DOI":"10.1007\/s11883-014-0401-9","article-title":"Pathophysiology of Acute Coronary Syndrome","volume":"16","author":"Santos-Gallego","year":"2014","journal-title":"CURR ATHEROSCLER REP."},{"issue":"15","key":"10.1016\/j.intimp.2022.108938_b0515","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1001\/jama.2021.0716","article-title":"Oral antiplatelet therapy after acute coronary syndrome","volume":"325","author":"Kamran","year":"2021","journal-title":"JAMA."},{"issue":"18","key":"10.1016\/j.intimp.2022.108938_b0520","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.3390\/jcm10184132","article-title":"Acute coronary syndrome in the older patient","volume":"10","author":"Garc\u00eda-Blas","year":"2021","journal-title":"J. CLIN. MED."},{"issue":"1","key":"10.1016\/j.intimp.2022.108938_b0525","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/CIRCRESAHA.111.243162","article-title":"Regulation of the inflammatory response in cardiac repair","volume":"110","author":"Frangogiannis","year":"2012","journal-title":"CIRC. RES."},{"issue":"6","key":"10.1016\/j.intimp.2022.108938_b0530","first-page":"893","article-title":"Calcium-Sensing Receptor on Neutrophil Promotes Myocardial Apoptosis and Fibrosis After Acute Myocardial Infarction via NLRP3 Inflammasome Activation","volume":"36","author":"Ren","year":"2020","journal-title":"CAN. J. CARDIOL."},{"issue":"6","key":"10.1016\/j.intimp.2022.108938_b0535","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.7150\/thno.39072","article-title":"Inflammatory extracellular vesicles prompt heart dysfunction via TRL4-dependent NF-\u03baB activation","volume":"10","author":"Biemmi","year":"2020","journal-title":"THERANOSTICS."},{"issue":"4","key":"10.1016\/j.intimp.2022.108938_b0540","first-page":"382","article-title":"Inflammatory markers in ST-elevation acute myocardial infarction","volume":"5","author":"Seropian","year":"2016","journal-title":"Eur. Heart J. Acute Cardiovascular Care."},{"issue":"1","key":"10.1016\/j.intimp.2022.108938_b0545","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1161\/CIRCRESAHA.119.315309","article-title":"Letter by Wang et al Regarding Article, \u201cInterleukin-35 promotes macrophage survival and improves wound healing after myocardial infarction in mice\u201d","volume":"125","author":"Wang","year":"2019","journal-title":"CIRC. RES."},{"issue":"7","key":"10.1016\/j.intimp.2022.108938_b0550","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1007\/s00259-020-04736-8","article-title":"Angiotensin-converting enzyme inhibitor treatment early after myocardial infarction attenuates acute cardiac and neuroinflammation without effect on chronic neuroinflammation","volume":"47","author":"Borchert","year":"2020","journal-title":"EUR. J. NUCL. MED. MOL. I."},{"key":"10.1016\/j.intimp.2022.108938_b0555","article-title":"Targeting cardiovascular inflammation: next steps in clinical translation","author":"Lawler","year":"2020","journal-title":"EUR. HEART J."},{"issue":"12","key":"10.1016\/j.intimp.2022.108938_b0560","doi-asserted-by":"crossref","first-page":"e52490","DOI":"10.1371\/journal.pone.0052490","article-title":"Decreased plasma IL-35 levels are related to the left ventricular ejection fraction in coronary artery diseases","volume":"7","author":"Lin","year":"2012","journal-title":"PLOS ONE."},{"issue":"2","key":"10.1016\/j.intimp.2022.108938_b0565","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/cvr\/cvv255","article-title":"Deficiency of IL-12p35 improves cardiac repair after myocardial infarction by promoting angiogenesis","volume":"109","author":"Kan","year":"2016","journal-title":"CARDIOVASC RES."},{"issue":"4","key":"10.1016\/j.intimp.2022.108938_b0570","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1161\/CIRCRESAHA.119.316514","article-title":"Letter by belmadani et al regarding article, \u201cinterleukin-35 promotes macrophage survival and improves wound healing after myocardial infarction in mice\u201d","volume":"126","author":"Belmadani","year":"2020","journal-title":"CIRC. RES."},{"issue":"11","key":"10.1016\/j.intimp.2022.108938_b0575","doi-asserted-by":"crossref","DOI":"10.1007\/s11886-019-1235-4","article-title":"Pulmonary arterial hypertension: a pharmacotherapeutic update","volume":"21","author":"Coons","year":"2019","journal-title":"CURR. CARDIOL. REP."},{"issue":"10","key":"10.1016\/j.intimp.2022.108938_b0580","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1164\/rccm.201103-0412OC","article-title":"A novel murine model of severe pulmonary arterial hypertension","volume":"184","author":"Ciuclan","year":"2011","journal-title":"AM. J. RESP. CRIT. CARE."},{"issue":"6","key":"10.1016\/j.intimp.2022.108938_b0585","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.201709-1835OC","article-title":"Endothelial and smooth muscle cell interaction via FoxM1 signaling mediates vascular remodeling and pulmonary hypertension","volume":"198","author":"Dai","year":"2018","journal-title":"AM. J. RESP. CRIT. CARE."},{"issue":"17","key":"10.1016\/j.intimp.2022.108938_b0590","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jacc.2009.01.004","article-title":"ACCF\/AHA 2009 Expert Consensus Document on Pulmonary Hypertension","volume":"53","author":"McLaughlin","year":"2009","journal-title":"J. AM. COLL. CARDIOL."},{"issue":"1","key":"10.1016\/j.intimp.2022.108938_b0595","doi-asserted-by":"crossref","first-page":"1801887","DOI":"10.1183\/13993003.01887-2018","article-title":"Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives","volume":"53","author":"Humbert","year":"2019","journal-title":"EUR. RESPIR J."},{"issue":"3","key":"10.1016\/j.intimp.2022.108938_b0600","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000111548","article-title":"Increased regulatory and decreased CD8+ cytotoxic T cells in the blood of patients with idiopathic pulmonary arterial hypertension","volume":"75","author":"Ulrich","year":"2008","journal-title":"RESPIRATION."},{"key":"10.1016\/j.intimp.2022.108938_b0605","doi-asserted-by":"crossref","first-page":"111081","DOI":"10.1016\/j.biopha.2020.111081","article-title":"Characteristics of inflammation process in monocrotaline-induced pulmonary arterial hypertension in rats","volume":"133","author":"Tang","year":"2021","journal-title":"BIOMED. PHARMACOTHER."},{"issue":"8","key":"10.1016\/j.intimp.2022.108938_b0610","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1161\/CIRCRESAHA.110.236927","article-title":"Regulatory T cells limit vascular endothelial injury and prevent pulmonary hypertension","volume":"109","author":"Tamosiuniene","year":"2011","journal-title":"CIRC. RES."},{"issue":"12","key":"10.1016\/j.intimp.2022.108938_b0615","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1016\/j.celrep.2019.05.061","article-title":"TCF1 and LEF1 control treg competitive survival and Tfr development to prevent autoimmune diseases","volume":"27","author":"Yang","year":"2019","journal-title":"CELL REP."},{"issue":"4","key":"10.1016\/j.intimp.2022.108938_b0620","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4103\/2045-8932.105031","article-title":"New models of pulmonary hypertension based on VEGF receptor blockade-induced endothelial cell apoptosis","volume":"2","author":"Nicolls","year":"2012","journal-title":"PULM CIRC."},{"issue":"2","key":"10.1016\/j.intimp.2022.108938_b0625","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1165\/rcmb.2011-0015OC","article-title":"Pharmacologic agents elevating cAMP prevent arginase II expression and proliferation of pulmonary artery smooth muscle cells","volume":"47","author":"Chen","year":"2012","journal-title":"AM. J. RESP. CELL MOL."},{"issue":"4","key":"10.1016\/j.intimp.2022.108938_b0630","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.3892\/mmr.2014.3106","article-title":"Regulatory T cells protect against hypoxia-induced pulmonary arterial hypertension in mice","volume":"11","author":"Chu","year":"2015","journal-title":"MOL. MED. REP."},{"issue":"11","key":"10.1016\/j.intimp.2022.108938_b0635","doi-asserted-by":"crossref","first-page":"926","DOI":"10.21037\/atm-21-1952","article-title":"Tregs-derived interleukin 35 attenuates endothelial proliferation through STAT1 in pulmonary hypertension","volume":"9","author":"Wan","year":"2021","journal-title":"Annals of Translational Med."},{"issue":"4","key":"10.1016\/j.intimp.2022.108938_b0640","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.ajpath.2011.06.037","article-title":"Paigen diet-fed apolipoprotein E knockout mice develop severe pulmonary hypertension in an interleukin-1\u2013dependent manner","volume":"179","author":"Lawrie","year":"2011","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.intimp.2022.108938_b0645","doi-asserted-by":"crossref","first-page":"9535","DOI":"10.1002\/jcp.27642","article-title":"MicroRNA-140-5p targeting tumor necrosis factor-\u03b1 prevents pulmonary arterial hypertension","volume":"234","author":"Zhu","year":"2019","journal-title":"J. CELL PHYSIOL."},{"key":"10.1016\/j.intimp.2022.108938_b0650","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01480","article-title":"Interleukin-1 Receptor antagonist protects newborn mice against pulmonary hypertension","volume":"10","author":"Bui","year":"2019","journal-title":"FRONT IMMUNOL."},{"issue":"9470","key":"10.1016\/j.intimp.2022.108938_b0655","first-page":"1577","article-title":"Abdominal aortic aneurysm","volume":"365","author":"Sakalihasan","year":"2005","journal-title":"Abdominal aortic aneurysm. LANCET."},{"issue":"10","key":"10.1016\/j.intimp.2022.108938_b0660","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.18632\/aging.101702","article-title":"Abdominal aortic aneurysm in aged population","volume":"12","author":"Umebayashi","year":"2018","journal-title":"Aging (Albany NY)."},{"issue":"12","key":"10.1016\/j.intimp.2022.108938_b0665","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/01.ATV.0000245819.32762.cb","article-title":"Abdominal Aortic Aneurysm","volume":"26","author":"Golledge","year":"2006","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology."},{"issue":"13","key":"10.1016\/j.intimp.2022.108938_b0670","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1042\/CS20190399","article-title":"Enhanced endoplasmic reticulum and mitochondrial stress in abdominal aortic aneurysm","volume":"133","author":"Navas-Madro\u00f1al","year":"2019","journal-title":"CLIN. SCI."},{"issue":"4","key":"10.1016\/j.intimp.2022.108938_b0675","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/1753944717750338","article-title":"Differential mRNA expression of inflammasome genes NLRP1 and NLRP3 in abdominal aneurysmal and occlusive aortic disease","volume":"12","author":"Gonzalez-Hidalgo","year":"2018","journal-title":"Therapeutic Adv. Cardiovascular Dis."},{"key":"10.1016\/j.intimp.2022.108938_b0680","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/9450843","article-title":"Silencing IL12p35 promotes angiotensin II-mediated abdominal aortic aneurysm through activating the STAT4 Pathway","volume":"2021","author":"Wang","year":"2021","journal-title":"MEDIAT. INFLAMM."},{"key":"10.1016\/j.intimp.2022.108938_b0685","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/6967310","article-title":"Characterization of CD4+T Cell Subsets in Patients with Abdominal Aortic Aneurysms","volume":"2018","author":"T\u00e9o","year":"2018","journal-title":"MEDIAT. INFLAMM."},{"key":"10.1016\/j.intimp.2022.108938_b0690","doi-asserted-by":"crossref","unstructured":"Iida Y, Tanaka H, Hu X, et al(2014)EBI3 Deficiency Exacerbates Experimental Abdominal Aortic Aneurysms. ARTERIOSCL THROM VAS. 34. doi.","DOI":"10.1161\/atvb.34.suppl_1.104"},{"issue":"11","key":"10.1016\/j.intimp.2022.108938_b0695","doi-asserted-by":"crossref","first-page":"6124","DOI":"10.1172\/JCI122732","article-title":"EBV-induced gene 3 augments IL-23R\u03b1 protein expression through a chaperone calnexin","volume":"130","author":"Mizoguchi","year":"2020","journal-title":"J. CLIN. INVEST."},{"issue":"2","key":"10.1016\/j.intimp.2022.108938_b0700","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2174\/1570161115666170413145705","article-title":"Pharmacological therapy of abdominal aortic aneurysm: an update","volume":"16","author":"Wang","year":"2018","journal-title":"CURR. VASC PHARMACOL."},{"key":"10.1016\/j.intimp.2022.108938_b0705","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ebiom.2018.06.009","article-title":"Interleukin-12p35 Knock Out aggravates doxorubicin-induced cardiac injury and dysfunction by aggravating the inflammatory response, oxidative stress, apoptosis and autophagy in mice","volume":"35","author":"Ye","year":"2018","journal-title":"EBIOMEDICINE."},{"issue":"9","key":"10.1016\/j.intimp.2022.108938_b0710","doi-asserted-by":"crossref","first-page":"e24272","DOI":"10.1371\/journal.pone.0024272","article-title":"Impaired Thymic Export and apoptosis contribute to regulatory T-cell defects in patients with chronic heart failure","volume":"6","author":"Tang","year":"2011","journal-title":"PLOS ONE."},{"issue":"20","key":"10.1016\/j.intimp.2022.108938_b0715","first-page":"1518","article-title":"The regulatory activity of interleukin-35 on CD14(+)monocytes in patients with chronic heart failure","volume":"101","author":"Yu","year":"2021","journal-title":"Zhonghua Yi Xue Za Zhi."},{"issue":"1","key":"10.1016\/j.intimp.2022.108938_b0720","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1161\/CIRCRESAHA.115.303895","article-title":"Foxp3+CD4+T Cells improve healing after myocardial infarction by modulating monocyte\/macrophage differentiation","volume":"115","author":"Weirather","year":"2014","journal-title":"CIRC. RES."},{"issue":"3","key":"10.1016\/j.intimp.2022.108938_b0725","article-title":"Activated T lymphocytes are essential drivers of pathological remodeling in ischemic heart failure. circulation","volume":"10","author":"Bansal","year":"2017","journal-title":"Heart Failure."},{"issue":"11","key":"10.1016\/j.intimp.2022.108938_b0730","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMra071667","article-title":"Myocardial reperfusion injury","volume":"357","author":"Yellon","year":"2007","journal-title":"NEW ENGL. J. MED."},{"issue":"5","key":"10.1016\/j.intimp.2022.108938_b0735","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/heartjnl-2015-307855","article-title":"Reducing myocardial infarct size: challenges and future opportunities","volume":"102","author":"Bulluck","year":"2016","journal-title":"HEART."},{"issue":"14","key":"10.1016\/j.intimp.2022.108938_b0740","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.jacc.2015.02.032","article-title":"Evolving therapies for myocardial ischemia\/reperfusion injury","volume":"65","author":"Ib\u00e1\u00f1ez","year":"2015","journal-title":"J. AM. COLL. CARDIOL."},{"issue":"2","key":"10.1016\/j.intimp.2022.108938_b0745","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1096\/fj.201901718RR","article-title":"Interleukin 35 ameliorates myocardial ischemia-reperfusion injury by activating the gp130-STAT3 axis","volume":"34","author":"Zhou","year":"2020","journal-title":"The FASEB Journal."},{"issue":"11","key":"10.1016\/j.intimp.2022.108938_b0750","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1056\/NEJMe1509718","article-title":"Targeting myocardial reperfusion injury \u2014 the search continues","volume":"373","author":"Hausenloy","year":"2015","journal-title":"NEW ENGL. J. MED."},{"issue":"9","key":"10.1016\/j.intimp.2022.108938_b0755","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.4049\/jimmunol.1700717","article-title":"Interaction of neutrophils with macrophages promotes IL-1\u03b2 maturation and contributes to hepatic ischemia-reperfusion injury","volume":"199","author":"Sadatomo","year":"2017","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2022.108938_b0760","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1089\/ars.2016.6940","article-title":"Lymphocyte communication in myocardial ischemia\/reperfusion injury","volume":"26","author":"Boag","year":"2017","journal-title":"ANTIOXID. REDOX. SIGN."},{"issue":"7","key":"10.1016\/j.intimp.2022.108938_b0765","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1007\/s11064-018-2560-5","article-title":"IL-35 is a protective immunomodulator in brain ischemic injury in mice","volume":"43","author":"Xu","year":"2018","journal-title":"NEUROCHEM. RES."},{"issue":"4","key":"10.1016\/j.intimp.2022.108938_b0770","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/abbs\/gmab007","article-title":"Interleukin 35 protects cardiomyocytes following ischemia\/reperfusion-induced apoptosis via activation of mitochondrial STAT3","volume":"53","author":"Zhou","year":"2021","journal-title":"ACTA BIOCH. BIOPH. SIN."},{"issue":"7","key":"10.1016\/j.intimp.2022.108938_b0775","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/jama.283.7.897","article-title":"The international registry of acute aortic dissection (IRAD)","volume":"283","author":"Hagan","year":"2000","journal-title":"JAMA."},{"issue":"1","key":"10.1016\/j.intimp.2022.108938_b0780","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7994","article-title":"Granulocyte macrophage colony-stimulating factor is required for aortic dissection\/intramural haematoma","volume":"6","author":"Son","year":"2015","journal-title":"NAT. COMMUN."},{"issue":"4","key":"10.1016\/j.intimp.2022.108938_b0785","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1161\/CIRCRESAHA.116.304918","article-title":"Adventitial CXCL1\/G-CSF expression in response to acute aortic dissection triggers local neutrophil recruitment and activation leading to aortic rupture","volume":"116","author":"Anzai","year":"2015","journal-title":"CIRC. RES."},{"issue":"3","key":"10.1016\/j.intimp.2022.108938_b0790","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/CIRCRESAHA.115.308040","article-title":"Smad4 Deficiency in smooth muscle cells initiates the formation of aortic aneurysm","volume":"118","author":"Zhang","year":"2016","journal-title":"CIRC. RES."},{"key":"10.1016\/j.intimp.2022.108938_b0795","first-page":"1","article-title":"Circulating Th1, Th2, Th9, Th17, Th22, and Treg levels in aortic dissection patients","volume":"2018","author":"Ye","year":"2018","journal-title":"MEDIAT INFLAMM."},{"issue":"360","key":"10.1016\/j.intimp.2022.108938_b0800","first-page":"1526","article-title":"Myocarditis","volume":"15","author":"Jr","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.intimp.2022.108938_b0805","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1161\/CIRCRESAHA.115.306573","article-title":"Myocarditis","volume":"118","author":"Fung","year":"2016","journal-title":"Myocarditis. CIRC. RES."},{"issue":"21","key":"10.1016\/j.intimp.2022.108938_b0810","doi-asserted-by":"crossref","first-page":"10785","DOI":"10.1128\/JVI.76.21.10785-10790.2002","article-title":"V\u03b34+T Cells promote autoimmune CD8+Cytolytic T-lymphocyte activation in coxsackievirus B3-induced myocarditis in mice: role for CD4+Th1 cells","volume":"76","author":"Huber","year":"2002","journal-title":"J. VIROL."},{"issue":"9","key":"10.1016\/j.intimp.2022.108938_b0815","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1007\/s00705-014-2098-z","article-title":"In vivo delivery of interleukin-35 relieves coxsackievirus-B3-induced viral myocarditis by inhibiting Th17 cells","volume":"159","author":"Hu","year":"2014","journal-title":"ARCH VIROL."},{"key":"10.1016\/j.intimp.2022.108938_b0820","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.yjmcc.2014.04.002","article-title":"Oleanolic acid modulates the immune-inflammatory response in mice with experimental autoimmune myocarditis and protects from cardiac injury. therapeutic implications for the human disease","volume":"72","author":"Mart\u00edn","year":"2014","journal-title":"J. MOL. CELL CARDIOL."},{"issue":"12","key":"10.1016\/j.intimp.2022.108938_b0825","doi-asserted-by":"crossref","first-page":"6661","DOI":"10.4049\/jimmunol.1100315","article-title":"Cutting Edge: human regulatory T cells require IL-35 To mediate suppression and infectious tolerance","volume":"186","author":"Chaturvedi","year":"2011","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2022.108938_b0830","doi-asserted-by":"crossref","first-page":"7144","DOI":"10.4049\/jimmunol.0902739","article-title":"IL-35 stimulation of CD39+regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10","volume":"184","author":"Kochetkova","year":"2010","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2022.108938_b0835","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4049\/jimmunol.174.1.261","article-title":"IL-12 Protects against Coxsackievirus B3-Induced Myocarditis by Increasing IFN-\u03b3 and macrophage and neutrophil populations in the heart","volume":"174","author":"Fairweather","year":"2005","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2022.108938_b0840","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1042\/CS20140511","article-title":"IL-35 inhibits HBV antigen-specific IFN-\u03b3-producing CTLsin vitro","volume":"129","author":"Li","year":"2015","journal-title":"CLIN. SCI."},{"key":"10.1016\/j.intimp.2022.108938_b0845","doi-asserted-by":"crossref","unstructured":"Zhang Y, Wei S, Wu Q, et al(2022)Interleukin-35 promotes Breg expansion and interleukin-10 production in CD19+ B cells in patients with ankylosing spondylitis. CLIN RHEUMATOL. doi: 10.1007\/s10067-022-06137-8.","DOI":"10.1007\/s10067-022-06137-8"},{"key":"10.1016\/j.intimp.2022.108938_b0850","doi-asserted-by":"crossref","DOI":"10.36660\/abc.20200945","article-title":"N\u00edveis de interleucina-35 em pacientes com doen\u00e7a arterial coronariana est\u00e1vel","author":"Oflar","year":"2021","journal-title":"ARQ BRAS CARDIOL."},{"key":"10.1016\/j.intimp.2022.108938_b0855","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/6012795","article-title":"Interleukin 35 Polymorphisms Are associated with decreased risk of premature coronary artery disease, metabolic parameters, and IL-35 levels: the genetics of atherosclerotic disease (GEA) study","volume":"2017","author":"Posadas-S\u00e1nchez","year":"2017","journal-title":"MEDIAT. INFLAMM."},{"issue":"5","key":"10.1016\/j.intimp.2022.108938_b0860","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/MCA.0000000000000635","article-title":"Association between interleukin-35 polymorphisms and coronary heart disease in the Chinese Zhuang population","volume":"29","author":"Lin","year":"2018","journal-title":"CORONARY ARTERY DIS."},{"issue":"1","key":"10.1016\/j.intimp.2022.108938_b0865","article-title":"Analysis for interaction between interleukin-35 genes polymorphisms and risk factors on susceptibility to coronary heart disease in the Chinese Han population","volume":"21","author":"Li","year":"2021","journal-title":"BMC CARDIOVASC DISOR."},{"issue":"1","key":"10.1016\/j.intimp.2022.108938_b0870","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cyto.2013.04.037","article-title":"Stimulated human peripheral T cells produce high amounts of IL-35 protein in a proliferation-dependent manner","volume":"64","author":"Guttek","year":"2013","journal-title":"CYTOKINE."},{"issue":"1","key":"10.1016\/j.intimp.2022.108938_b0875","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4049\/jimmunol.1401145","article-title":"Ex vivo-expanded but not in vitro-induced human regulatory T cells are candidates for cell therapy in autoimmune diseases thanks to stable demethylation of the FOXP3 regulatory T cell-specific demethylated region","volume":"194","author":"Rossetti","year":"2015","journal-title":"J. IMMUNOL."},{"issue":"8","key":"10.1016\/j.intimp.2022.108938_b0880","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20187334","article-title":"PD-1\/PD-L1 regulates treg differentiation in pregnancy-induced hypertension","volume":"51","author":"Jiang","year":"2018","journal-title":"BRAZ J. MED. BIOL. RES."},{"key":"10.1016\/j.intimp.2022.108938_b0885","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/410232","article-title":"Erythromycin enhancescd4+Foxp3+ regulatory T-Cell responses in a rat model of smoke-induced lung inflammation","volume":"2012","author":"Bai","year":"2012","journal-title":"MEDIAT. INFLAMM."},{"issue":"4","key":"10.1016\/j.intimp.2022.108938_b0890","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s12031-014-0443-z","article-title":"Circulating levels of interleukin-35 in patients with multiple sclerosis: evaluation of the influences of FOXP3 gene polymorphism and treatment program","volume":"55","author":"Jafarzadeh","year":"2015","journal-title":"J. MOL. NEUROSCI."},{"issue":"1","key":"10.1016\/j.intimp.2022.108938_b0895","doi-asserted-by":"crossref","DOI":"10.1186\/s12985-019-1158-0","article-title":"Interleukin-35 modulates the balance between viral specific CD4+CD25+CD127dim\/- regulatory T cells and T helper 17 cells in chronic hepatitis B virus infection","volume":"16","author":"Yang","year":"2019","journal-title":"VIROL J."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922004222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922004222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:54:55Z","timestamp":1761587695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922004222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":179,"alternative-id":["S1567576922004222"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.108938","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-35 ameliorates cardiovascular disease by suppressing inflammatory responses and regulating immune homeostasis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.108938","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108938"}}